Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRI Trial: Glycopyrronium vs Hyoscine for Drooling in Children with Neurodisability
2013-000863-94Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Sep 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in None and Neurodevelopmental disorder (NDD) comparing Glycopyrronium bromide arm with Hyoscine patch arm (2 arms). Primary endpoint: Drooling Impact Scale score at 4 weeks. Started Sep 2013; status: completed.
02
Drugs
glycopyrroniumscopolamine
03
Conditions
Neurodevelopmental disorder (NDD)
Beyond the preview
Go deeper on 2013-000863-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000863-94.